In English
NIDA

Menu

Inicio

Ciencia de la adicción

Desire to Smoke Subsides, But Cigarette Cues Retain Power

During early abstinence, smokers’ cravings triggered by cigarette cues intensified over time, providing evidence that people can experience a phenomenon previously observed in experiments with animals

Etiquetas

Alleviation of Posttraumatic Stress Disorder May Improve Addiction Treatment

Women with posttraumatic stress disorder (PTSD) who abused drugs responded better to substance abuse treatment after their PTSD symptoms improved, according to a recent study, which also found that reductions in substance abuse did not ease PTSD severity

Etiquetas

Research Focuses on Groups With High Smoking Rates

NIDA Director Nora Volkow
Dr. Volkow discusses NIDA’s efforts to develop effective antismoking treatments for populations with persistently high rates of smoking, such as people with psychiatric disorders, high school dropouts, and Native Americans.

Etiquetas

Blending conference translates substance abuse research into practice

Experts will share the latest clinical research with addiction treatment professionals, healthcare providers, policy makers, and others during the April 19th Blending Conference in Atlanta, Georgia.

Etiquetas

Study provides clues for designing new anti-addiction medications

Scientists are now one step closer to developing anti-addiction medications, thanks to new research that provides a better understanding of the properties of the only member of the opioid receptor family whose activation counteracts the rewarding effects of addictive drugs.

Etiquetas

In Animals, Receptor Puts Brakes on Nicotine Consumption

New research suggests that differences in tobacco consumption reflect, in part, differences in the functional efficacy of a specific type of receptor in a pathway of the brain. In animal studies, nicotinic acetylcholine receptors with the α5 subunit played a key role in producing aversive responses to nicotine, thereby dissuading further consumption of the drug.

Etiquetas

NIDA Announces Avant-Garde Medication Development Awards

Dr. Thomas Kosten of Baylor College of Medicine and Dr. Peter Burkhard of the University of Connecticut are the recipients of NIDA’s 2011 Avant-Garde Awards for Innovative Medication Development Research. Dr. Kosten is developing a vaccine against methamphetamine abuse and Dr. Burkhard is developing a vaccine to counter nicotine addiction.

Etiquetas

Desafío nacional sobre el Coeficiente Intelectual (IQ) de las drogas

Un examen de 12 preguntas que anima a las personas a poner a prueba su conocimiento sobre el abuso de drogas y la adicción. Las respuestas muestran el enlace entre la ciencia y el abuso de drogas.

Actualizada en: diciembre del 2012
Autor: Array

Etiquetas

Stimulant Abusers' Regard for Future Improves With Memory Training

Researchers correlate stimulant abusers’ improved performance on a memory training exerc ise with reductions in delay discounting.

Etiquetas

Pages

Subscribe to RSS - Ciencia de la adicción

Toma el reto nacional sobre el coeficiente intelectual (CI) sobre las drogas